Cargando…

Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT

We report a 49-year-old male with castration-resistant prostate cancer (CRPC) with oligometastasis diagnosed by <sup>11</sup>C-choline positron emission tomography-computed tomography (PET/CT) and treated with target radiotherapy. In the diagnosis of CRPC (serum prostate-specific antigen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitajima, Kazuhiro, Yamamoto, Shingo, Fujiwara, Masayuki, Suzuki, Hitomi, Yoshimura, Nahomi, Kunimoto, Ryo, Yokoyama, Hiroyuki, Komoto, Hisashi, Yamada, Yusuke, Nagasawa, Seiji, Kanematsu, Akihiro, Oh, Ryoong-Jin, Yamakado, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879290/ https://www.ncbi.nlm.nih.gov/pubmed/33613236 http://dx.doi.org/10.1159/000512068

Ejemplares similares

Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Accurate Monitoring of the Response of Bone Metastases to Treatment in Patients with Prostate Cancer Using Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

CT Findings of Primary Renal Angiosarcoma
por: Komoto, Hisashi, et al.
Publicado: (2021)

Diagnostic performance of (11)C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

(11)C-Choline-Avid but (18)F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography
por: Kitajima, Kazuhiro, et al.
Publicado: (2016)

The Potential Use of 11C-Choline Positron Emission Tomography/Computed Tomography to Monitor the Treatment Effects of Radium-223 in a Patient with Prostate Cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Quantitative bone SPECT/CT for evaluating treatment response in patient with sternoclavicular arthritis
por: Komoto, Hisashi, et al.
Publicado: (2022)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Clinical Experience of Percutaneous Radiofrequency Ablation Using an arfa RF ABLATION SYSTEM(Ⓡ) in Various Organs
por: Kinota, Naoya, et al.
Publicado: (2022)

Comparison of 11C-choline Positron Emission Tomography/Computed Tomography (PET/CT) and Conventional Imaging for Detection of Recurrent Prostate Cancer
por: Kawanaka, Yusuke, et al.
Publicado: (2018)

MRI Finding of Prostatic Ductal Adenocarcinoma
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

(11)C-Choline positive but (18)F-FDG negative pancreatic metastasis from renal cell carcinoma on PET
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

A case of repeat oligoprogressive castration‐resistant prostate cancer treated with pulmonary metastasectomy
por: Soma, Takahiko, et al.
Publicado: (2023)

Fluorodeoxyglucose versus Choline Positron Emission Tomography/Computed Tomography Response Evaluation in Two Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Neoadjuvant Chemotherapy
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

CT and MRI Findings of Inflammatory Myofibroblastic Tumor in the Bladder
por: Furukawa, Yoshitaka, et al.
Publicado: (2022)

Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer—Prevalence and Current Clinical Practice
por: Patel, Priyanka H., et al.
Publicado: (2022)

Pelvic MRI, FDG-PET/CT, and Somatostatin Receptor Scintigraphy Findings of Treatment-Related Neuroendocrine-Differentiated Prostate Cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Usefulness of Quantitative Bone Single Photon Emission Computed Tomography/Computed Tomography for Evaluating Response to Neoadjuvant Chemotherapy in a Patient with Periosteal Osteosarcoma
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer
por: Nguyen, Thu-Cuc, et al.
Publicado: (2018)

Use of Microballoon Catheter in Transarterial Ethanol Embolization of Renal Angiomyolipoma: A Retrospective Comparative Study with Historical Control?
por: Taniguchi, Junichi, et al.
Publicado: (2022)

Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma
por: Doi, Hiroshi, et al.
Publicado: (2018)

Oligoprogression in Non-Small Cell Lung Cancer
por: Harada, Daijiro, et al.
Publicado: (2021)

Untangling a Knotted Angiographic Catheter Using a Balloon Catheter: A Case Report
por: Takahagi, Motonori, et al.
Publicado: (2023)

Quantitative Bone Single Photon Emission Computed Tomography/Computed Tomography for Evaluating Response to Bisphosphonate Treatment in Patients with Paget's Disease of Bone
por: Kitajima, Kazuhiro, et al.
Publicado: (2020)

The Management of Oligoprogression in the Landscape of New Therapies for Metastatic Melanoma
por: Guida, Michele, et al.
Publicado: (2019)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
por: Alomran, Reem, et al.
Publicado: (2021)

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
por: Schoenhals, Jonathan E., et al.
Publicado: (2021)

Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements
por: Pisano, Chiara, et al.
Publicado: (2022)

Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2023)

Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma
por: Hashimoto, Masaki, et al.
Publicado: (2022)

Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial
por: Kitajima, Kazuhiro, et al.
Publicado: (2023)

The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?
por: Patel, P.H., et al.
Publicado: (2019)

Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review
por: Yaney, Alexander, et al.
Publicado: (2022)

Oligoprogression in non-small cell lung cancer: a narrative review
por: Nguyen, Katarina T., et al.
Publicado: (2022)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
por: König, Laila, et al.
Publicado: (2020)

Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations
por: Rossi, Antonio, et al.
Publicado: (2022)

Usefulness of Quantitative Bone SPECT/CT for Evaluating Treatment Response in a Patient with Mandibular Osteomyelitis
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ulcpm24qlafk102a223joknuk